| manager |
|
| language |
- |
| license |
- |
| created at |
2017-12-21 11:07:16 UTC |
| updated at |
2017-12-21 12:22:32 UTC |
|
2 layers
|
143,100 entries
|
There is 0 pattern entry.
|
metabolic type
|
CONC:NCI_NCI-GLOSS |
|
|
cosegregation
|
CONC:NCI_NCI-GLOSS |
|
|
best practice
|
CONC:NCI_NCI-GLOSS |
|
|
Protection of Human Subjects
|
CONC:NCI_NCI-GLOSS |
|
|
human participant protection regulations
|
CONC:NCI_NCI-GLOSS |
|
|
45 Code of Federal Regulations Part 46
|
CONC:NCI_NCI-GLOSS |
|
|
45 CFR 46
|
CONC:NCI_NCI-GLOSS |
|
|
lymphocytic
|
CONC:NCI_NCI-GLOSS |
|
|
anti-VEGFR monoclonal antibody
|
CONC:NCI_NCI-GLOSS |
|
|
sesquiterpene lactone
|
CONC:NCI_NCI-GLOSS |
|
|
calendula ointment
|
CONC:NCI_NCI-GLOSS |
|
|
bench-to-bedside
|
CONC:NCI_NCI-GLOSS |
|
|
extragonadal
|
CONC:NCI_NCI-GLOSS |
|
|
unresected
|
CONC:NCI_NCI-GLOSS |
|
|
noninvasive
|
CONC:NCI_NCI-GLOSS |
|
